Report cards › Companies › Vertex Pharmaceuticals
Vertex Pharmaceuticals: Political money and lobbying (shown, not graded) records
Political money and lobbying (shown, not graded): 205 records from the U.S. Senate Office of Public Records (LDA.gov), from 2021 to 2026; 202 of them list an amount, $29,700,000 in all. Political money and lobbying (shown, not graded): 3 records from the Federal Election Commission, from 2022 to 2026; the amounts total $844,987. Outcomes as recorded: $415,487.00 to federal candidates' committees (2025-2026) (1), $231,000.00 to federal candidates' committees (2023-2024) (1), $198,500.00 to federal candidates' committees (2021-2022) (1).
Newest first; records 101 to 150 of 208. Each links to the agency's own record. Back to the report card.
| Date | Agency | What the agency recorded | Amount or outcome | Record | Retrieved | Matched | Report |
|---|---|---|---|---|---|---|---|
| Oct 21, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: STANTON PARK GROUP reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2024 (3rd Quarter - Report); issues HCR; bills named: H.R. 7142, S. 3832 | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 19, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: EMPIRE CONSULTING GROUP reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2024 (3rd Quarter - Report); issues HCR; bills named: H.R. 7142, S. 127 | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 18, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: VERTEX PHARMACEUTICALS INCORPORATED reported $1,000,000.00 (expenses) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2024 (3rd Quarter - Report); issues BUD, HCR, MMM, TAX; bills named: H.R. 830, S. 1375, H.R. 7421, S. 3832, H.R. 8774, S. 4921, H.R. 8580, S. 4677, H.R. 9029, S. 4942 | $1,000,000 · $1,000,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 18, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TARPLIN, DOWNS & YOUNG, LLC reported $80,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2024 (3rd Quarter - Report); issues BUD, HCR, MMM; bills named: H.R. 7142, S. 3838 | $80,000 · $80,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 13, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TIBER CREEK GROUP reported $80,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS in the 3rd Quarter (July 1 - Sep 30) of 2024 (3rd Quarter - Report); issues HCR; bills named: H.R. 7142, S. 3832 | $80,000 · $80,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 22, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CROSSROADS STRATEGIES, LLC reported $30,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 2nd Quarter (Apr 1 - June 30) of 2024 (2nd Quarter - Report); issues HCR, MED, MMM; bills named: S. 3832, H.R. 7142 | $30,000 · $30,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 22, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: AVENUE SOLUTIONS reported $60,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 2nd Quarter (Apr 1 - June 30) of 2024 (2nd Quarter - Report); issues HCR, MMM; bills named: H.R. 7142, S. 3832, S. 2973, H.R. 5378, S. 1339 | $60,000 · $60,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 22, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: STANTON PARK GROUP reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 2nd Quarter (Apr 1 - June 30) of 2024 (2nd Quarter - Report); issues HCR | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 20, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: EMPIRE CONSULTING GROUP reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 2nd Quarter (Apr 1 - June 30) of 2024 (2nd Quarter - Report); issues HCR; bills named: S. 3832, S. 127 | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 17, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TARPLIN, DOWNS & YOUNG, LLC reported $80,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 2nd Quarter (Apr 1 - June 30) of 2024 (2nd Quarter - Report); issues BUD, HCR, MMM, TAX | $80,000 · $80,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 15, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: VERTEX PHARMACEUTICALS INCORPORATED reported $980,000.00 (expenses) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 2nd Quarter (Apr 1 - June 30) of 2024 (2nd Quarter - Report); issues HCR, MMM; bills named: H.R. 830, S. 1375, H.R. 7085, H.R. 7142, S. 3832 | $980,000 · $980,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 14, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TIBER CREEK GROUP reported $80,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS in the 2nd Quarter (Apr 1 - June 30) of 2024 (2nd Quarter - Report); issues HCR; bills named: H.R. 7142, S. 3832 | $80,000 · $80,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 22, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: STANTON PARK GROUP reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 1st Quarter (Jan 1 - Mar 31) of 2024 (1st Quarter - Report); issues HCR | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 22, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CROSSROADS STRATEGIES, LLC reported $30,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 1st Quarter (Jan 1 - Mar 31) of 2024 (1st Quarter - Report); issues HCR, MED, MMM; bills named: S. 3832, H.R. 7142 | $30,000 · $30,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 22, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: AVENUE SOLUTIONS reported $60,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 1st Quarter (Jan 1 - Mar 31) of 2024 (1st Quarter - Report); issues HCR, HOM, MMM; bills named: S. 2973, H.R. 5378, S. 1339, H.R. 4366, H.R. 2882 | $60,000 · $60,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 19, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: EMPIRE CONSULTING GROUP reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 1st Quarter (Jan 1 - Mar 31) of 2024 (1st Quarter - Report); issues HCR | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 18, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: VERTEX PHARMACEUTICALS INCORPORATED reported $1,150,000.00 (expenses) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 1st Quarter (Jan 1 - Mar 31) of 2024 (1st Quarter - Report); issues HCR, MMM, TAX; bills named: H.R. 830, S. 1375, H.R. 7085, H.R. 2673, S. 866, H.R. 7142, S. 3832 | $1,150,000 · $1,150,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 16, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TARPLIN, DOWNS & YOUNG, LLC reported $80,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 1st Quarter (Jan 1 - Mar 31) of 2024 (1st Quarter - Report); issues BUD, HCR, MMM, TAX | $80,000 · $80,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 15, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TIBER CREEK GROUP reported $80,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS in the 1st Quarter (Jan 1 - Mar 31) of 2024 (1st Quarter - Report); issues HCR, MMM; bills named: H.R. 7142, S. 3832 | $80,000 · $80,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 22, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: AVENUE SOLUTIONS reported $60,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 4th Quarter (Oct 1 - Dec 31) of 2023 (4th Quarter - Report); issues HCR, MMM; bills named: S. 2973, H.R. 5378, S. 1339 | $60,000 · $60,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 22, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: STANTON PARK GROUP reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 4th Quarter (Oct 1 - Dec 31) of 2023 (4th Quarter - Report); issues HCR | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 20, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CROSSROADS STRATEGIES, LLC reported $30,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 4th Quarter (Oct 1 - Dec 31) of 2023 (4th Quarter - Report); issues BUD, HCR, MED, MMM | $30,000 · $30,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 18, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TARPLIN, DOWNS & YOUNG, LLC reported $80,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 4th Quarter (Oct 1 - Dec 31) of 2023 (4th Quarter - Report); issues BUD, HCR, MMM, TAX | $80,000 · $80,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 18, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: EMPIRE CONSULTING GROUP reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 4th Quarter (Oct 1 - Dec 31) of 2023 (4th Quarter - Report); issues HCR | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 18, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: VERTEX PHARMACEUTICALS INCORPORATED reported $920,000.00 (expenses) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 4th Quarter (Oct 1 - Dec 31) of 2023 (4th Quarter - Report); issues HCR, MMM, TAX; bills named: H.R. 830, S. 1375, H.R. 2673, S. 866 | $920,000 · $920,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 14, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TIBER CREEK GROUP reported $80,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS in the 4th Quarter (Oct 1 - Dec 31) of 2023 (4th Quarter - Report); issues HCR, MMM | $80,000 · $80,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 20, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: STANTON PARK GROUP reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2023 (3rd Quarter - Report); issues HCR | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 20, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: AVENUE SOLUTIONS reported $60,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2023 (3rd Quarter - Report); issues MMM | $60,000 · $60,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 20, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CROSSROADS STRATEGIES, LLC reported $30,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2023 (3rd Quarter - Report); issues BUD, HCR, MED, MMM | $30,000 · $30,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 19, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TARPLIN, DOWNS & YOUNG, LLC reported $80,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2023 (3rd Quarter - Report); issues BUD, HCR, MMM, TAX | $80,000 · $80,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 19, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: EMPIRE CONSULTING GROUP reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2023 (3rd Quarter - Report); issues HCR | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 19, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: VERTEX PHARMACEUTICALS INCORPORATED reported $890,000.00 (expenses) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2023 (3rd Quarter - Report); issues BUD, HCR, MMM, TAX; bills named: H.R. 830, S. 1375, H.R. 2673, S. 866 | $890,000 · $890,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 13, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TIBER CREEK GROUP reported $80,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS in the 3rd Quarter (July 1 - Sep 30) of 2023 (3rd Quarter - Report); issues HCR, MMM | $80,000 · $80,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Aug 28, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: AVENUE SOLUTIONS reported $20,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 2nd Quarter (Apr 1 - June 30) of 2023 (2nd Quarter - Report); issues MMM | $20,000 · $20,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 20, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CROSSROADS STRATEGIES, LLC reported $10,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 2nd Quarter (Apr 1 - June 30) of 2023 (2nd Quarter - Report); issues BUD, HCR, MED, MMM | $10,000 · $10,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 20, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: STANTON PARK GROUP reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 2nd Quarter (Apr 1 - June 30) of 2023 (2nd Quarter - Report); issues HCR | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 19, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: EMPIRE CONSULTING GROUP reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 2nd Quarter (Apr 1 - June 30) of 2023 (2nd Quarter - Report); issues HCR | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 19, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: VERTEX PHARMACEUTICALS INCORPORATED reported $630,000.00 (expenses) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 2nd Quarter (Apr 1 - June 30) of 2023 (2nd Quarter - Report); issues BUD, HCR, MMM, TAX; bills named: H.R. 830, S. 1375, H.R. 2673, S. 866 | $630,000 · $630,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 18, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TARPLIN, DOWNS & YOUNG, LLC reported $80,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 2nd Quarter (Apr 1 - June 30) of 2023 (2nd Quarter - Report); issues BUD, HCR, MMM, TAX | $80,000 · $80,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 14, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TIBER CREEK GROUP reported $80,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS in the 2nd Quarter (Apr 1 - June 30) of 2023 (2nd Quarter - Report); issues HCR | $80,000 · $80,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 21, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TARPLIN, DOWNS & YOUNG, LLC reported $80,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 1st Quarter (Jan 1 - Mar 31) of 2023 (1st Quarter - Report); issues BUD, HCR, MMM, TAX | $80,000 · $80,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 20, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: STANTON PARK GROUP reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 1st Quarter (Jan 1 - Mar 31) of 2023 (1st Quarter - Report); issues HCR | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 19, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: WILLIAMS AND JENSEN, PLLC reported $30,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 1st Quarter (Jan 1 - Mar 31) of 2023 (1st Quarter - Report); issues BUD, HCR, MED, MMM | $30,000 · $30,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 19, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: VERTEX PHARMACEUTICALS INCORPORATED reported $670,000.00 (expenses) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 1st Quarter (Jan 1 - Mar 31) of 2023 (1st Quarter - Report); issues BUD, HCR, MMM, TAX | $670,000 · $670,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 19, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: EMPIRE CONSULTING GROUP reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 1st Quarter (Jan 1 - Mar 31) of 2023 (1st Quarter - Report); issues HCR | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 17, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CAPITOL COUNSEL LLC reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 1st Quarter (Jan 1 - Mar 31) of 2023 (1st Quarter - Report); issues MMM, PHA, TAX | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 16, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TIBER CREEK GROUP reported $80,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS in the 1st Quarter (Jan 1 - Mar 31) of 2023 (1st Quarter - Report); issues HCR | $80,000 · $80,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 20, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TARPLIN, DOWNS & YOUNG, LLC reported $80,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 4th Quarter (Oct 1 - Dec 31) of 2022 (4th Quarter - Report); issues BUD, HCR, MMM, TAX; bills named: H.R. 2617, H.R. 5376, H.R. 6000, S. 4348, H.R. 7667, H.R. 1319 | $80,000 · $80,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 20, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: STANTON PARK GROUP reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 4th Quarter (Oct 1 - Dec 31) of 2022 (4th Quarter - Report); issues HCR | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 20, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: WILLIAMS AND JENSEN, PLLC reported $30,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 4th Quarter (Oct 1 - Dec 31) of 2022 (4th Quarter - Report); issues BUD, HCR, MED, MMM, TAX; bills named: S. 586 | $30,000 · $30,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
CSWH is not affiliated with these agencies.